Skip to search formSkip to main contentSkip to account menu

Cotara

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

iodine I 131 monoclonal antibody TNT-1/B

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Abstract 2454: In vivo binding of chTNT-1/B antibodies (Cotara) to DNA/histone complexes in tumors using near-infrared optical imaging
Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL Tumors contain both microscopic and macroscopic… 
Review
2010
Review
2010
Handbook of therapeutic antibodies : technologies, emerging developments and approved therapeutics
Section I: Technologies Foreword A Greeting from the Editor PART 0: INTRODUCTION Therapeutic Antibodies - From Past to Future… 
2009
2009
Efficacy of a Novel Intratumoral Radio Immunotherapeutic Agent Cotara Delivered via Convection-Enhanced Delivery in Recurrent Glioblastoma Multiforme: An Initial Single Institutional Experience with…
2009
2009
Efficacy of Intratumoral Radioimmunotherapeutic Agent Cotara Dispensed with Convection-Enhanced Delivery in Recurrent Glioblastoma Multiforme: An Initial Experience with 7 Cases
2009
2009
Minimally Invasive Dorsal Root Entry Zone Operation: Experimental Surgical Evidence
2008
2008
Open-label, dose confirmation, and dosimetry study of interstitial 131I-chTNT-1/B MAb for the treatment of recurrent glioblastoma multiforme (GBM): Final results.
2039 Background: Interstitial 131I-chTNT-1/B MAb (Cotara) is a radioiodinated chimeric monoclonal antibody specific for DNA and… 
2008
2008
Abciximab, Arcitumomab, Basiliximab, Capromab, Cotara, Daclizumab, Edrecolomab, Ibritumomab, Igovomab, Nofetumomab, Satumomab, Sulesomab, Tositumomab, and Votumumab
2006
2006
Toxicity and biodistribution of an iodine-131-radiolabelled tumour necrosis-targeting antibody in non-tumour-bearing domestic felines.
The potential of human immunotherapeutics now revolutionizing modern cancer therapy has yet to make an impact in veterinary… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)